Table 2.
Characterization of eGFR groups
| eGFR group (eGFR range (mL/min/1.73 m2)) | CKD stage | N samples | N men (%) | Mean age (SD) | N medication (%) |
|---|---|---|---|---|---|
| 1 (≥60) | 1 + 2 | 27 | 19 (70.4) | 60.6 (13.2) | 21 (84.0) |
| 2 (45 – <60) | 3A | 29 | 23 (79.3) | 68.5 (10.4) | 21 (72.4) |
| 3 (30 – <45) | 3B | 31 | 19 (61.3) | 70.8 (11.6) | 16 (51.6) |
| 4 (15 – <30) | 4 | 52 | 30 (57.7) | 72.5 (10.5) | 30 (61.2) |
| 5 (<15) | 5 | 129 | 75 (58.1) | 67.8 (14.0) | 67 (54.0) |
| Total | 268 | 166 (61.9) | 68.4 (13.0) | 155 (60.1) |
ATC code C9: agents acting on the renin–angiotensin system; CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate; SD: standard deviation.